Literature DB >> 472964

Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study.

P Jacobs, L A Wormald, M C Gregory.   

Abstract

Free iron in the circulation in contrast to iron complexed with protein or carbohyrdate, is intensely toxic. The annual morbidity and mortality from accidental overdose with iron salts is significant and has directed attention to the evaluation of safer forms of therapy. Comparative studies between oral ferrous sulphate and iron polymaltose in rats established an LD100 of 350 mg/kg for the salt, whereas neither morbidity nor mortality could be produced in doses exceeding 1 000 mg/kg for the complex. Bio-availability of iron from salt and complex for haemoglobin synthesis was then compared both in rats and in man with a twin-isotope technique. In experimental animals and in the human studies, venesected individuals were used to reproduce the iron deficiency state where treatment would be indicated. It was concluded that bioavailability is comparable for therapeutic doses of ferrous sulphate and iron polymaltose in iron-deficient subjects. The marginally lower absorption of complex was offset by a greater degree of gastrointestinal tract tolerance; the wide margin of safety may be of importance in reducing the danger of accidental iron overdose.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 472964

Source DB:  PubMed          Journal:  S Afr Med J


  5 in total

1.  [Bioavailability of trivalent iron contained in an oral preparation of iron III-hydroxide-dextrin complex].

Authors:  H C Heinrich; R Fischer; E E Gabbe; N Theobald
Journal:  Klin Wochenschr       Date:  1983-01-17

2.  Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women.

Authors:  Lekha Saha; Promila Pandhi; Sarala Gopalan; Samir Malhotra; Pradip Kumar Saha
Journal:  MedGenMed       Date:  2007-01-02

3.  Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia.

Authors:  Beril Yasa; Leyla Agaoglu; Emin Unuvar
Journal:  Int J Pediatr       Date:  2011-10-31

Review 4.  Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview.

Authors:  Palacios Santiago
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  The pharmacokinetics and pharmacodynamics of iron preparations.

Authors:  Peter Geisser; Susanna Burckhardt
Journal:  Pharmaceutics       Date:  2011-01-04       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.